These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 24847781)

  • 21. Serum adiponectin, interleukin-10 levels and inflammatory markers in the metabolic syndrome.
    Choi KM; Ryu OH; Lee KW; Kim HY; Seo JA; Kim SG; Kim NH; Choi DS; Baik SH
    Diabetes Res Clin Pract; 2007 Feb; 75(2):235-40. PubMed ID: 16872712
    [TBL] [Abstract][Full Text] [Related]  

  • 22. C-reactive protein, interleukin-6, and tumor necrosis factor-alpha levels in overweight and healthy adults.
    Chaikate S; Harnroongroj T; Chantaranipapong Y; Puduang S; Mahaisiriyodom A; Viroonudomphol D; Singhasivanon P; Schelp FP; Tornee S; Tribunyatkul S; Changbumrung S
    Southeast Asian J Trop Med Public Health; 2006 Mar; 37(2):374-81. PubMed ID: 17125002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relation between C-reactive protein and body mass index in patients with polycystic ovarian syndrome.
    Moradi S; Mollabashi M; Kerman SR
    Gynecol Endocrinol; 2011 Jul; 27(7):480-5. PubMed ID: 20836727
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The association between inflammatory biomarkers and metabolically healthy obesity depends of the definition used.
    Marques-Vidal P; Velho S; Waterworth D; Waeber G; von Känel R; Vollenweider P
    Eur J Clin Nutr; 2012 Apr; 66(4):426-35. PubMed ID: 21952696
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of homeostasis model assessment of insulin resistance, adiponectin, and low-grade inflammation with the course of the metabolic syndrome.
    Ding Y; Li S; Ma RL; Guo H; Zhang J; Zhang M; Liu J; Guo S
    Clin Biochem; 2015 May; 48(7-8):503-7. PubMed ID: 25700597
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reciprocal contribution of pentraxin 3 and C-reactive protein to obesity and metabolic syndrome.
    Ogawa T; Kawano Y; Imamura T; Kawakita K; Sagara M; Matsuo T; Kakitsubata Y; Ishikawa T; Kitamura K; Hatakeyama K; Asada Y; Kodama T
    Obesity (Silver Spring); 2010 Sep; 18(9):1871-4. PubMed ID: 20111016
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of clinical and inflammatory markers of nonalcoholic fatty liver disease in postmenopausal women with metabolic syndrome.
    Rodrigues MH; Bruno AS; Nahas-Neto J; Sandrim VC; Muniz LG; Nahas EA
    Metab Syndr Relat Disord; 2014 Aug; 12(6):330-8. PubMed ID: 25051240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subclinical inflammation during third trimester of pregnancy was not associated with markers of the metabolic syndrome in young adult offspring.
    Danielsen I; Granström C; Rytter D; Halldorsson TI; Bech BH; Henriksen TB; Stehouwer CD; Schalkwijk CG; Vaag AA; Olsen SF
    Obesity (Silver Spring); 2014 May; 22(5):1351-8. PubMed ID: 24167021
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulin resistance, inflammatory biomarkers, and adipokines in patients with chronic kidney disease: effects of angiotensin II blockade.
    de Vinuesa SG; Goicoechea M; Kanter J; Puerta M; Cachofeiro V; Lahera V; Gómez-Campderá F; Luño J
    J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S206-12. PubMed ID: 17130263
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inflammatory biomarkers and oxidative stress measurements in patients with systemic lupus erythematosus with or without metabolic syndrome.
    Lozovoy MA; Simão AN; Hohmann MS; Simão TN; Barbosa DS; Morimoto HK; Reiche EM; Cecchini R; Dichi I
    Lupus; 2011 Nov; 20(13):1356-64. PubMed ID: 21868433
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monocyte chemoattractant protein-1 is related to metabolic syndrome and homocysteine in subjects without clinically significant atherosclerotic cardiovascular disease.
    Kim SH; Lee JW; Im JA; Hwang HJ
    Scand J Clin Lab Invest; 2011 Feb; 71(1):1-6. PubMed ID: 21073393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between plasma resistin concentrations, inflammatory chemokines, and components of the metabolic syndrome in adults.
    Aquilante CL; Kosmiski LA; Knutsen SD; Zineh I
    Metabolism; 2008 Apr; 57(4):494-501. PubMed ID: 18328350
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of short-term fenofibrate treatment on circulating markers of inflammation and hemostasis in patients with impaired glucose tolerance.
    Okopień B; Krysiak R; Herman ZS
    J Clin Endocrinol Metab; 2006 May; 91(5):1770-8. PubMed ID: 16492702
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of the relationship of leptin, high-sensitivity C-reactive protein, adiponectin, insulin, and uric acid to metabolic syndrome in lean, overweight, and obese young females.
    Abdullah AR; Hasan HA; Raigangar VL
    Metab Syndr Relat Disord; 2009 Feb; 7(1):17-22. PubMed ID: 19025443
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Waist circumference is positively correlated with markers of inflammation and negatively with adiponectin in women with metabolic syndrome.
    Ackermann D; Jones J; Barona J; Calle MC; Kim JE; LaPia B; Volek JS; McIntosh M; Kalynych C; Najm W; Lerman RH; Fernandez ML
    Nutr Res; 2011 Mar; 31(3):197-204. PubMed ID: 21481713
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Obesity is the major determinant of elevated C-reactive protein in subjects with the metabolic syndrome.
    Aronson D; Bartha P; Zinder O; Kerner A; Markiewicz W; Avizohar O; Brook GJ; Levy Y
    Int J Obes Relat Metab Disord; 2004 May; 28(5):674-9. PubMed ID: 14993913
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systemic and vascular markers of inflammation in relation to metabolic syndrome and insulin resistance in adults with elevated atherosclerosis risk.
    Kressel G; Trunz B; Bub A; Hülsmann O; Wolters M; Lichtinghagen R; Stichtenoth DO; Hahn A
    Atherosclerosis; 2009 Jan; 202(1):263-71. PubMed ID: 18501910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Waist circumference is the main determinant of elevated C-reactive protein in metabolic syndrome.
    Nakamura H; Ito H; Egami Y; Kaji Y; Maruyama T; Koike G; Jingu S; Harada M
    Diabetes Res Clin Pract; 2008 Feb; 79(2):330-6. PubMed ID: 17964679
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiple abnormalities in glucose and energy metabolism and coordinated changes in levels of adiponectin, cytokines, and adhesion molecules in subjects with metabolic syndrome.
    Salmenniemi U; Ruotsalainen E; Pihlajamäki J; Vauhkonen I; Kainulainen S; Punnonen K; Vanninen E; Laakso M
    Circulation; 2004 Dec; 110(25):3842-8. PubMed ID: 15596567
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inflammatory/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment.
    Ansell BJ; Navab M; Hama S; Kamranpour N; Fonarow G; Hough G; Rahmani S; Mottahedeh R; Dave R; Reddy ST; Fogelman AM
    Circulation; 2003 Dec; 108(22):2751-6. PubMed ID: 14638544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.